Blood Screening Leads Revival of China’s National Blood Program

Blood Screening Leads Revival of China’s National Blood Program

Investment in screening diagnostics is pivotal in China’s effort to strengthen its scandal-bitten national blood program. Kalorama Information’s recently published Blood Testing Market in China provides IVD-relevant insights into both regional and national demand for blood screening products in China. Blood supply in China is insufficient today to meeting clinical demand in China, but increased donation is being encouraged as blood centers update screening standards and works to improve transfus...


Top Infectious Diseases in the IVD Market - Hepatitis

Top Infectious Diseases in the IVD Market - Hepatitis

The following analysis is derived from Kalorama Information’s recently released global market research report: The Worldwide Market for Infectious Disease Diagnostic Tests.

This is the third in a series of five posts outlining the leading infectious diseases or infectious disease groups in terms of IVD market sales. Previous posts were for HIV/AIDS and respiratory tract infection tests.

Tests for viral hepatitis infections, primarily hepatitis C virus (HCV) and hepatitis B virus (HBV), are a...

  • by esalazar@marketresearch.com
  • January 30 2015
  • blood
  • plasma


Plasma Is Stronger than Blood - What to Expect in Blood-Related Device, Diagnostic and Biopharma Markets

Plasma Is Stronger than Blood - What to Expect in Blood-Related Device, Diagnostic and Biopharma Markets

The expansion of viable, safe blood collection systems remains a challenge in the developing world; established economies - where the bulk of the global blood products market is found - face a far different form of market transition. The volume of blood transfusions in the United States is declining: between 2009 and 2014 blood transfusions fell approximately by one third according to the American Red Cross. Recent blood transfusion statistics from Europe show a similarly negative trend. Lower t...